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DIFFERENTIAL  EFFECTS  OF  CHLORPROMAZINE  ON  THE 
IN  VITRO  GENERATION  AND 
EFFECTOR  FUNCTION  OF  CYTOTOXIC  LYMPHOCYTES* 
BY  RONALD M.  FERGUSON,$ JON  R.  SCHMIDTKE,  AND RICHARD  L.  SIMMONS 
(From the Department  of Surgery, University of Minnesota Hospitals,  Minneapolis, 
Minnesota 55455) 
Allograft rejection represents a cytotoxic response mediated to a large degree 
by thymus-derived T lymphocytes (1). The study of such cell-mediated cytotoxic 
phemonena has been greatly facilitated by the discovery first noted by H~iyry 
and Defendi (2) and Wunderlich and Canty (3), that a natural consequence of 
allogeneic stimulation in an undirectional mixed lymphocyte culture (MLC) was 
the  appearance  of cytotoxic  lymphocytes  specific for antigens present on the 
stimulator cell. Subsequent studies have shown that such in vitro generation of 
cytotoxic lymphocytes was dependent on the proliferative response in an MLC 
(4),  was  genetically  determined  (5),  and possibly required  the  interaction  of 
several subpopulations of T cells (6). 
We  now report  that  the  surface  active  agent  chlorpromazine:  (a)  inhibits 
allogeneic stimulation of the proliferative response in an MLC; (b) inhibits the 
MLC generation of cytotoxic lymphocytes,  (c) has no effect on the recognition, 
binding, or lysis of target cells by already sensitized lymphocytes; and (d) blocks 
a postproliferative membrane-mediated event, independent of proliferation, and 
necessary for the MLC generation of cytotoxic lymphocytes. 
Materials and Methods 
Animals.  3- to 6-mo-old female BALB/c (H-2 d) and C57BL/6  (H-2 b) mice were obtained from 
The Jackson Laboratory, Bar Harbor, Maine. 
Cell Preparations.  Spleens were removed with aseptic technique and minced through a no. 40 
stainless steel mesh, washed twice with cold minimal essential medium. Red blood cells were 
removed by a 3 min incubation at 25°C in 0.01 M Tris-0.83% NH4C1. 
In Vitro  Sensitization.  4  x  l0  s  BALB/c responder cells were added with 0.5  x  los C57BL/6 
stimulator cells (previously irradiated with 2,000 rads) (C57X) in 2 ml to 16mM plastic tissue cul- 
ture plates (Linbro Chemical Company, New Haven, Conn.). Spleen cells were cultured in a modi- 
fied Eagle's medium (Grand Island Biological Co., Grand Island, N. Y.) supplemented with 10% 
fetal  calf  serum  (FCS)  (Microbiological  Associates,  Bethesda, Md.),  1%  penicillin  and  streptomycin, 
2 mM  glutamine, and 2-mercaptoethanol (5 × 10  -5 M). 
Cytotoxicity Assay.  Direct cell-mediated cytotoxicity  was assayed by a modification of the 
methods described  by Hodes et al. (7).  Cells  from the above cultures  were collected  and washed 
twice in the Eagle's  medium. They were then incubated with 51Cr-labeled  EL4 (H-2  ~) ceils 
(maintained by serial  passage in C57BL/6 mice) in ratios  of  8:1,  4:1,  and 2:1 (lymphocytes:EL4 
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cells).  These  mixtures  were  incubated  for  4  h in  modified Eagle's  medium at  37°C.  The  mixture  was 
centrifuged at 2,500  rprn;  the supernate was removed and 51Cr  activity  counted in a Nuclear 
Chicago  Automatic  gamma counter  (Nuclear-Chicago Corp.,  Des  Plaines,  Ill.).  Maximum obtaina- 
ble s~Cr  release was determined when distilled  water was added to 51Cr-labeled  EL4 cells. 
Spontaneous  s~Cr  release  was  determined  by  incubating  s~Cr-labeled  EL4  cells  alone  at  37°C for  4  h. 
Percent  lysis  was calculated  as  follows: 
percent Lysis -experimental sICr  cpm - spontaneous  s]Cr5  cpm x 100. 
total  s~Cr  cpm - spontaneous  5~Cr  cpm 
Proliferation  Assay.  Proliferative  assays were performed in 0.2 ml of the above described 
supplemented media in 6-mm plastic  culture  plates (Linbro Chemical Co.). 8 x  10  s responder 
BAI,B/c  cells  were  mixed  with 1 x 10  ~  stimulator  C57BL/6 (previously  irradiated  with  2,000  rads). 
18  h before  harvesting,  each  culture  was pulsed with 1 ~Ci of  [3H]thymidine ([3H]TdR) sp act  6.7 
Ci/mmol (new England Nuclear, Boston, Mass.). 
Results and Discussion 
Effect of  Chlorpromazine (CPZ) on the Proliferative Response in the MLC.  If 
CPZ was added to responder cells in culture at the same time as the stimulator 
cells,  subsequent  incorporation  of increased  tritiated  thymidine  uptake  was 
diminished or totally inhibited in a dose-dependent manner. At a CPZ concentra- 
tion  of 5  ×  10  -5  M  total  inhibition  of stimulated  3H  uptake  was  observed, 
whereas 5 ×  10  -e M CPZ produced only 50% inhibition.  If CPZ was added after 
24,  48,  or  72  h  of exposure  of the  responder  and  stimulator  cells,  [3H]TdR 
incorporation proceeded in a  pattern similar to the control untreated cultures, 
despite the presence of the drug for the majority of the culture period. This was 
particularly striking for 5  x  10  -s M CPZ (Fig.  1). 
Effect of CPZ Upon the MLC Generation of Cytotoxic Cells.  If CPZ (5 ×  10  -6 
M) was added to responder cells in an MLC at the same time as the stimulator 
cells, no demonstrable cytotoxic activity was generated, in addition to the above 
described partial  inhibition  of proliferative  responses.  If,  however,  the  same 
concentration of CPZ (5 ×  10  -e M) was added to cultures containing target cells 
and already sensitized MLC-generated effector cells (efferent phase), no inhibi- 
tion of killing was observed (Fig.  2). 
The Effect  of Delayed Addition of CPZ  Upon the  Generation of Cytotoxic 
Cells.  The effect of adding CPZ (5 ×  10  -6 M) to MLC's at successive intervals 
after exposure of stimulator  and responder cells in culture on the subsequent 
development of cytotoxic activity is shown in Fig. 3. If CPZ was added at 0 time, 
24  h,  or  48  h  after  culture  initiation,  no  significant  cytotoxic  activity  was 
generated during the 5-day culture period. If, however, CPZ was added at 72 or 
96 h (after culture initiation), full expression of cytotoxic activity was generated. 
Again,  addition  of CPZ  (5  x  10  -6 M) had  no effect on the  ability of already 
sensitized effector cells to lyse target cells. 
The Relationship  between the CPZ Inhibition of  Proliferation and Generation 
of Cytotoxic Lyrnphocytes.  The differential effect of CPZ-induced inhibition of 
MLC-stimulated  [~H]TdR uptake  and  generation  of cytotoxic lymphocytes is 
shown in Fig. 4.  Using parallel experiments,  measuring thymidine incorpora- 
tion  and  generation  of cytotoxic lymphocytes, it can be seen that if CPZ was 
added to cultures at 48 h considerable incorporation of [3H]TdR was observed but 234  FERGUSON  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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FIG.  1.  The effect of the addition of two concentrations of CPZ (5 x  10-SMand5 x  10-SM), 
at various intervals after MLC initiation, on the subsequent PH]TdR uptake.  MLC's were 
performed as described. The hours shown represent the hour of culture that CPZ was added. 
That the drug was not toxic is demonstrated,  for a  full proliferative response is shown, 
despite the presence of CPZ from 48 to 96 h before harvest (or 24-48 h after culture). A dose- 
dependent inhibition is also demonstrated. 
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FIG.  2.  Effect of CPZ (5  x  10  -8 M) on the MLC sensitization of BLBL/c spleen cells and 
effector function of already sensitized BALB/c cells. Sensitization and cytotoxic assays were 
performed as described in the Materials and Methods.  CPZ was present throughout the 
entire culture period of the afferent (sensitization culture) and efferent (cytetoxic assay) 
phases. 
virtually no cytotoxic lymphocytes were generated.  If, however, CPZ was added 
after 72 or 96 h of culture a full cytotoxic response in addition to full proliferative 
activity was observed. 
CPZ has been shown to bind to and inhibit a variety of cell surface phenomena 
(8).  It also binds to and inhibits responses of lymphocytes to various mitogens 
(reference  9 and footnote  1).  The data presented here demonstrate differential 
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FIG. 3.  Effect of adding CPZ (5 x  10  -e M) to the afferent (MLC sensitization) culture  at 
various  intervals  after  culture initiation  on the subsequent  generation  of cytotoxic cells 
assayed ai~r the standard  5-day culture. (O--C)), MLC culture with no CPZ. (O---O), CPZ 
(5 x 10  -e M) added to the efferent (cytotoxicity) assay and not present in the afferent (MLC) 
assay. (A--A), CPZ (5 x 10  -e M) added to the afferent (MLC) assay at times indicated after 
culture initiation. 
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FIG. 4.  Time relationship  of  inhibition  by CPZ (5 x 10  -e M) of  MLC proliferation  and 
generation  ofcytotoxic  cells.  Proliferation  and  cytotoxicity  assayed  as  described.  Counts  per 
minute of  MLC are those  from day 5. Cells  were obtained  from day 5 MLC sensitization 
cultures  and assayed for  cytotoxic  activity. 
effects of  this  surface active drug on two phases of  in  vitro  cell-mediated immune 
responses. CPZ  inhibited the proliferative response of  an MLC  if  it was added 
within the first 24 h  of culture.  CPZ,  when added at 48 h,  also inhibited  the 
generation of cytotoxic lymphocytes by a  mechanism independent of prolifera- 
tion in the MLC. The drug, however, had no effect on the recognition, binding, 
and subsequent lysis of specific target cells by already sensitized effector cells. 
The mechanism of the CPZ-induced inhibition of allogeneic sensitization, prolif- 
eration, and generation of effector cells is not clear. Also, it is not clear why CPZ 236  FERGUSON  ET  AL.  BRIEF  DEFINITIVE  REPORT 
did  not  interfere with  binding  and  lysis  of target  cells  by  sensitized  cells. 
Extensive data from our laboratory have shown that CPZ was not cytotoxic to 
murine spleen cells and that its effects on mitogen-induced [3H]TdR uptake was 
completely reversible (reference 9 and footnote 1). 
Proliferation in a unidirectional MLC is thought to be less dependent upon ser- 
ologically defined (SD) surface H-2K and H-2D genetic desparity than on nonser- 
ologically definable loci (LD) which are themselves defined by MLC reactivity 
(10).  Lymphocytes from  congenic  strains  of mice  differing only  in  SD  loci 
stimulate a  weak mixed lymphocyte reaction (MLR)  and will  generate very 
minimal cytotoxic activity in a  MLC, whereas, murine lymphocytes from cer- 
tain H-2  (and therefore SD),  identical strains  stimulated a  relatively strong 
proliferative  response  in  an  MLC  but  generated few cytotoxic lymphocytes 
specific for the stimulating cell population (5). The cytotoxic specificity of MLC- 
generated effector cells is  generally considered tobe  located within the H-2 
surface antigenic sites (11). However, the nature of the interaction between the 
SD  and LD  loci and proliferation (all involved in the generation of cytotoxic 
lymphocytes) as  well as  the role of the LD and SD surface determinants in 
recognition and killing of effector cells of H-2  bearing specific target cells is 
poorly understood at the present time.  Cantor and Jandinski  (4) recently re- 
ported that cell division during a  critical early period of sensitization  and a 
subsequent division-independent period of differentiation was necessary for full 
cytotoxic expression. In addition, it would appear that both LD and SD antigenic 
disparity must be present to generate a  vigorous primary cytotoxic response 
(5, 9). It has also been demonstrated that synergism can exist between different 
subpopulations of T lymphocytes as demonstrated in in vitro primary cytotoxic 
responses showing that two T cells differing by the amounts of theta (Thy-l.2) 
antigen on their surface have been separated from spleen and found to synergize 
in cytotoxic responses generated in vitro (11). More recently Cantor et al.  (12) 
and Cantor and Boyse (13) have demonstrated, using the Ly antigen marker on 
T lymphocytes, that there are three subpopulations of T lymphocytes as demon- 
strated  by  differently Ly-marked populations,  Ly-l,2,3-;  Ly-1-;  and  Ly-2,3- 
bearing cells. Ly-l-positive cells have helper function in antihapten antibody 
responses and in proliferation in MLC's in response to LD differences. Cytotoxic 
lymphocytes, however, are derived from Ly-2,3-positive cells and have no demon- 
strable helper function and show little response to LD disparity. In addition, Ly- 
1-positive cells can synergize with  Ly-2,3-positive cells in  the  in  vitro  MLR 
generation of primary cytotoxic responses directed toward the SD antigens. 
One possible  explanation  of CPZ-induced inhibition  of these above events 
could involve an inhibition of cell interactions. In the case of cytotoxic lympho- 
cyte generation  it  is  possible  that  CPZ  prevents  a  necessary interaction of 
proliferating the precytotoxic cells. If these are one cell type, and the proliferat- 
ing  cells  eventually  become cytotoxic cells,  CPZ  could  perhaps  inhibit  the 
differentiation of such proliferating cells. If, however, the proliferating cell and 
the cytotoxic cell come from two different T-cell subpopulations, then perhaps 
the interaction of the Ly-1 helper cells (LD specific) (13, 14) with the precytoxic 
Ly-2,3 cells (SD specific) (13,  14)  at a  critical period between 48  and 72 h  of 
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the secretion of a soluble mediator active in producing differentiation of precyto- 
toxic cells and secreted by proliferating cells could be inhibited.  Although  the 
exact mechanism of action is not clear it seems reasonable that some surface- 
mediated process is involved.  The further use of a  pharmacologic approach to 
lymphocyte activation, differentiation, and effector cell killing by drugs such as 
CPZ  could  prove  useful  in  attempting  to  define  critical  membrane-mediated 
phenomena involved in such processes. 
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